Literature DB >> 5289423

Sites of action of amethopterin: intrinsic and acquired drug resistance.

K R Harrap, B T Hill, M E Furness, L I Hart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289423     DOI: 10.1111/j.1749-6632.1971.tb46986.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.

Authors:  A Ramu; M Fridkin; R Steinherz
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  The mechanism of differential sensitivity to methotrexate of normal and malignant human epidermal cells.

Authors:  M M Lee; J Ratliff; G B FitzGerald; M M Wick
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Isotope-dilution analysis of rate-limiting steps and pools affecting the incorporation of thymidine and deoxycytidine into cultured thymus cells.

Authors:  D A Sjostrom; D R Forsdyke
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

5.  Bioautographic visualization of dihydrofolate reductase in enzyme overproducing BHK mutants.

Authors:  S L Naylor; J K Townsend; R J Klebe
Journal:  Biochem Genet       Date:  1980-02       Impact factor: 1.890

6.  Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.

Authors:  C R Pinkerton; S G Welshman; J M Bridges
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

7.  Methotrexate and the need for continued research.

Authors:  F Rosenfelt
Journal:  Yale J Biol Med       Date:  1975-05

8.  Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.

Authors:  M J Embleton; M C Garnett; E Jacobs; R W Baldwin
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

9.  Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells.

Authors:  B T Hill; J H Goldie; L A Price
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.